What the CGM Boom Teaches Us About Wearable Design

The CGM boom is the most instructive thing to happen to wearable medical device design in a decade. Continuous glucose monitors went from niche clinical tool to mass consumer product in less than five years, and the companies that navigated that transition well taught the rest of the industry something worth paying attention to.

I want to be specific about what they actually figured out, because the lesson is not what most people think it is.

The Transition Was Not About Miniaturization

The common story about CGM success is that sensors got smaller, adhesives got better, and connectivity arrived. All of that is true. But miniaturization is an engineering achievement, not a design achievement. The companies that gained real market traction during the CGM boom did something harder: they redesigned the entire patient relationship with the device.

A CGM is not a device a patient uses occasionally. It is something they wear continuously, sleep in, shower with, and show to other people. The design problem is not how small can you make the sensor pod. The design problem is: what does it mean for a person to wear a medical device as part of their identity for months or years at a time?

That question is a wearable design question, and it is the question that separated the products that achieved real consumer adoption from the ones that stayed clinical.

What Wearable Design Actually Means in a Medical Context

Wearable design in medtech is not the same as wearable design in consumer electronics. The constraints are different, the stakes are different, and the user psychology is different.

A consumer wearable like a fitness tracker competes on aesthetics and feature sets. A medical wearable competes on trust. The patient wearing a CGM is not asking “does this look good?” first. They are asking “will this stay on, work correctly, and not draw attention I do not want to deal with?” Those are trust questions, and they are answered through design.

Specifically, the CGM category taught us several things about what trust-building wearable design looks like in a medical context:

Profile and discretion matter more than appearance. The most successful CGM form factors are low-profile ovals with smooth edges that disappear under clothing and do not catch on surfaces. The aesthetic is almost invisible. That invisibility is not a failure of design ambition. It is the design goal.

Adhesive and skin interface design is a clinical and a design problem simultaneously. The best sensors in the world fail commercially if the adhesive causes skin reactions, lifts early, or leaves residue. The skin interface is where the device spends its entire life. At Dip Studio, we treat adhesive integration as a core design constraint, not an afterthought assigned to manufacturing.

Color and material language communicate clinical competence and approachability at the same time. This is genuinely difficult. Medical white signals sterility. Consumer colors signal that the device is friendly. The CGM leaders found ways to navigate this tension, and studying their material choices is worth the time for any design team working in adjacent categories.

What This Means for Adjacent Wearable Categories

The CGM category is ahead of most other medical wearable segments on this design maturity curve. Cardiac monitoring patches, sleep apnea sensors, continuous blood pressure monitors, and chronic pain management wearables are all in earlier stages of the same transition: moving from clinical instruments used by patients into devices owned by patients.

The companies entering those categories now have the CGM playbook available to them. The design decisions that drove CGM adoption are not proprietary. They are learnable. The question is whether the design teams working on these new categories are asking the right questions early enough.

At Dip Studio, we have worked across wearable medical device categories, from the patient-worn MRIaudio headset we designed for GE HealthCare to wearable consumer electronics that share many of the same form, material, and user psychology constraints. The through-line is always the same: the device is not just a product. It is something a person agrees to incorporate into their life.

The Design Decision Most Teams Get Wrong

The most common mistake I see in medical wearable development is treating the on-body experience as a late-stage consideration. Teams spend months on sensor accuracy, wireless protocol, and regulatory pathway, and then arrive at industrial design with a form factor that is already locked by the PCB layout and battery size.

That sequence produces devices that work but do not get worn. Non-compliance in wearable medical devices is a major clinical and commercial problem. Patients who do not wear the device consistently do not get the clinical benefit. Devices that do not deliver clinical benefit do not generate the outcomes data that drives reimbursement and commercial scale.

Industrial design that is integrated from the beginning is not an aesthetic preference. It is a clinical strategy.